Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

2 months ago 14
Read Entire Article
  1. Homepage
  2. Finance
  3. Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

Related

Archer Aviation chief people partnerships officer sells shares for $521,931

Archer Aviation chief people partnerships officer sells shar...

23 minutes ago 0
US drops suit against Southwest Airlines over chronically delayed flights

US drops suit against Southwest Airlines over chronically de...

23 minutes ago 0
Archer Aviation CTO sells $1.05 million in stock

Archer Aviation CTO sells $1.05 million in stock

23 minutes ago 0

Trending

1. nba champions
2. jon stewart
3. kareem abdul-jabbar
4. julio rodriguez
5. dick van dyke
6. jack nicholson
7. ivan herrera
8. wlky
9. jennifer garner
10. ted lasso

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

3 months ago 184
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

2 months ago 129
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

4 months ago 125
TOUS les JOURS Opens in Henderson!

TOUS les JOURS Opens in Henderson!

3 months ago 97
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

3 months ago 91
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved